Skip to main content
PLOS ONE logoLink to PLOS ONE
. 2021 Nov 8;16(11):e0259743. doi: 10.1371/journal.pone.0259743

Functional analysis of N-acetylglucosaminyltransferase-I knockdown in 2D and 3D neuroblastoma cell cultures

M Kristen Hall 1, Adam P Burch 1, Ruth A Schwalbe 1,*
Editor: Salvatore V Pizzo2
PMCID: PMC8575246  PMID: 34748597

Abstract

Tumor development can be promoted/suppressed by certain N-glycans attached to proteins at the cell surface. Here we examined aberrant neuronal properties in 2D and 3D rat neuroblastoma (NB) cell cultures with different N-glycan populations. Lectin binding studies revealed that the engineered N-glycosylation mutant cell line, NB_1(-Mgat1), expressed solely oligomannose N-glycans, and verified that the parental cell line, NB_1, and a previous engineered N-glycosylation mutant, NB_1(-Mgat2), expressed significant levels of higher order N-glycans, complex and hybrid N-glycans, respectively. NB_1 grew faster than mutant cell lines in monolayer and spheroid cell cultures. A 2-fold difference in growth between NB_1 and mutants occurred much sooner in 2D cultures relative to that observed in 3D cultures. Neurites and spheroid cell sizes were reduced in mutant NB cells of 2D and 3D cultures, respectively. Cell invasiveness was highest in 2D cultures of NB_1 cells compared to that of NB_1(-Mgat1). In contrast, NB_1 spheroid cells were much less invasive relative to NB_1(-Mgat1) spheroid cells while they were more invasive than NB_1(-Mgat2). Gelatinase activities supported the ranking of cell invasiveness in various cell lines. Both palladin and HK2 were more abundant in 3D than 2D cultures. Levels of palladin, vimentin and EGFR were modified in a different manner under 2D and 3D cultures. Thus, our results support variations in the N-glycosylation pathway and in cell culturing to more resemble in vivo tumor environments can impact the aberrant cellular properties, particularly cell invasiveness, of NB.

Introduction

Neuroblastoma (NB), a tumor of neuronal origin, is most frequently found in infants and young children and is often associated with a bleak prognosis [1]. NB exists as one of the most common solid extracranial tumors in children, resulting in nearly 15% of pediatric cancer-related deaths [2]. While some NBs proliferate slowly and ultimately spontaneously regress, others proliferate and spread quickly [1]. These more aggressive forms of NB have proven challenging to treat, with only 40% of high-risk patients achieving long-term survival, despite recent therapeutics somewhat improving outcomes [1, 3]. Additional therapeutic approaches and treatments for NB are essential.

Glycosylation persists as the most complex post translational modification of proteins [1] and is implicated in numerous biological processes [4]. There are three types of N-glycans: oligomannose, hybrid, and complex. N-Acetylglucosaminyltransferases (GnTs), encoded by MGAT genes, create branch points on the conserved pentasaccharide of N-glycans to generate various types of N-glycans [4]. GnT-I initiates the conversion of oligomannose type N-glycans to hybrid type, which is further processed to complex type via GnT-II. Although it is known that alterations in glycan structure or glycan-glycan interactions effect cell proliferation and invasion [1, 2], uncertainty remains as to the roles of specific glycans on cancer development and progression [1]. For this reason, evaluation of N-glycans in cancer and glycan-based therapies are an attractive area of research for therapeutic development for cancer treatment.

Abnormal cell proliferation is essential for the progression of cancer and formation of tumors, of which, are capable of invading surrounding tissue. Traditionally, two-dimensional (2D) cell culture has been the foundation to investigate NB. Albeit these studies provide some insight into the development and progression of NB, 2D cell culture studies are insufficient in representing the three dimensional (3D) in vivo environment [5]. Spheroid cells, a 3D cell culture, more closely mimick the heterogeneity of in vivo tissues, including tumors, such that spheroids contain different populations of proliferating, differentiating, and viable cells in their various layers [6]. Studies of 2D and 3D cell cultures have demonstrated variation in expression of a tumor-associated antigen in carcinoma [7], protein expression patterns in human NB cell lines [5], and cancerous cellular processes [8]. The impact of 3D cultures on NB cell properties would contribute to a more comprehensive understanding of factors that promote and suppress NB.

Overexpression of matrix metalloproteinases (MMP), paladin, and vimentin are linked to modified cell morphology and invasiveness in cancer cells [911]. MMPs increase the availability of growth factors and cytokines to receptor tyrosine kinases (RTKs) by degrading the extracellular matrix [12]. Palladin, an actin cytoskeleton protein, is vital in neuronal maturation and development as well as neurite outgrowth [13]. Changes in cell motility and invasiveness have also been linked to alterations in the expression of the intermediate filament protein, vimentin [11, 14]. The RTK, epidermal growth factor receptor (EGFR), and glycolytic protein hexokinase-2 (HK2) influence cell growth and the overexpression of both have been linked to more invasive and aggressive cancers [1517]. Overexpression of HK2 has been associated with as much as 70% of cancers [15] and is a known participant in the Warburg Effect. We postulate that the expression and activity of these and other candidate proteins are dependent on the types N-glycans populating NB cells.

Previously, our lab demonstrated that knockdown of MGAT2/Mgat2 gene suppresses tumorgenicity in 2D cultured human [18] and rat NB cell lines [19, 20]. The knockdown of GnT-II prevents the conversion of hybrid to complex type N-glycans, thus yielding a glycosylation mutant cell line. Further, substitution of complex with hybrid types of N-glycans diminished aberrant NB cell properties [18, 20]. Given the implications of alterations in N-glycan processing on suppression/promotion of cancerous cell properties, herein, we further manipulate the N-glycan pathway via knockdown of Mgat1, thereby creating a mutant cell line with even less processed N-glycans. Lectin binding studies were employed to show that the N-glycans were mainly oligomannose type. In addition to our aim of examining changes in N-glycan processing on cell growth, dissociation, migration, and invasion, we aim to determine the impact of the microenvironment in which the cells are cultured, 2D versus 3D on those same cellular properties. Also, western blotting was used to distinguish if EGFR, hexokinase 2, palladin, and vimentin protein levels were altered among the three distinct cell lines, and further compare the levels between 2D and 3D cultured cell lines. Gelatin zymography assays were utilized to detect differences in MMP activity. Thus, this report demonstrates that interruption in the N-glycosylation pathway alter aberrant NB cell properties, and furthermore that 2D and 3D cultures are affected in a different manner.

Materials and methods

Cell lines, cell culture, and cell transfection

Rat B35 neuroblastoma (NB) (American Type Culture Collection, Manassas, VA, USA) were used to generate a clonal NB cell line, NB_1 [19]. Previously, we used CRISPR/Cas9 technology to silence rat Mgat2 gene [19] and those protocols were utilized to silence rat Mgat1 in the NB_1 clonal cell line, generating N-glycosylation mutant cell lines, referred to as NB_1(-Mgat2), and NB_1(-Mgat1), respectively. In brief, Zi-Fit Targeter software was used for designing Mgat1 sgRNA oligonucleotides 5’-CACCGTGCTATCATCTTTGTGGGC-3’ and 5’-AAAC GCCCACAAAGATGATAGCAC. Recombinant pSpCas9(BB)-2A-Puro vector (Addgene plasmid ID: 48139) encoding Mgat1 was employed to create the GnT-I knockout in NB_1 cells, referred to as NB_1(-Mgat1). After transfections, genomic DNA was isolated from some cells of a colony of NB_1(-Mgat1) cells and a fragment of the Mgat1 gene was amplified and cloned into pCR2.1 TOPO vector for DNA sequencing. DNA sequencing of 9 recombinant vectors showed frameshift mutations in Mgat1 and was used as the NB_1(-Mgat1). Further there was no alternative start codon, in frame, until residue 251. The remaining portion of cells were expanded and used for subsequent experiments. DMEM containing 10% FBS, 50 U/mL penicillin, and 50 μg/mL streptomycin at 37° was used in a 5% CO2 atmosphere to maintain 2D and 3D NB cell cultures. The NB_1(-Mgat1) cell line was rescued by transient transfection with pCDNA3.1 recombinant vector coding the mouse Mgat1 cDNA using the Lipofectamine® 2000 (Thermofisher Scientific, MA, USA) protocol [18]. The mouse Mgat1 coding sequence was obtained from Dr. Pamela Stanly, College of Albert Einstein [21] and was modified to have BamHI at both 5’ and 3’ ends using PCR and then cloned into pCDNA3.1 vector at the BamHI restriction site for expression in mammalian cell lines.

Whole cell lysates, total membranes and conditioned serum-free medium

RIPA buffer (PBS, 1% Triton X-100, 0.5% sodium deoxycholate, 0.1% SDS) plus protease inhibitor cocktail set III (EMD Biosciences, San Diega, CA, USA) was used to make whole cell lysates from 2D and 3D cell cultures, as we previously described [18]. Total membranes of 2D cell cultures, along with 3D cell cultures were purified as described [19]. Conditioned serum-free media was prepared as described [18], except cells were cultured in serum-free medium for 72–80 h, instead of 48 h. Further both 2D and 3D cell cultures were used to generate conditioned medium. In all cases, protein levels were determined by a modified Lowry assay. Whole cell lysates, total membrane, and conditioned medium samples were denatured and reduced in SDS-PAGE sample buffer, containing DTT for Coomassie blue stained gels and western blotting. Concentrated conditioned serum-free media samples were denatured in SDS-PAGE sample buffer for gel zymography. In all cases, aliquots of samples were stored at −20 or −80°C for future use.

2D cell proliferation assay

Cell proliferation was measured by employment of 5-bromo-2-deoxyuridine (BrdU) proliferation assays (Millipore, Billerica, MA) following the manufacturer’s protocol as previously documented [18]. 2 X 104 cells were plated in 96 well plates. Plated cells were incubated for 24 h before being fixed for 30 min at room temperature. Fixed cells were incubated for 1 h with anti-BrdU monoclonal antibody before a 30 min incubation with secondary goat-anti mouse IgG peroxidase conjugate. Absorbance was read at 450 nm using a Multiskan FC plate reader (Fisher Scientific, Atlanta, GA, USA) following a 30 min incubation with peroxidase substrate.

2D cell morphology assay

Cells were plated at low density on poly-lysine coated culture dishes (Mat-Tek, Ashland, MA, USA) and were incubated for 18 h before being imaged using a 10X objective on an Olympus IX71 microscope. Using Image J Software, outgrowth length and width were measured from the beginning of the cell body and halfway along the outgrowth length, respectively.

2D cell dissociation assay

Confluent CellBind Culture Dishes (Corning, NY, USA) were rinsed 2 times with DMEM before adding serum free media and detaching the cells using a cell scraper. Detached cells were pipetted ten times with a 1 mL pipet tip. Using a 10 X objective from a IX71 Olympus microscope, 25–30 fields per dish were captured for analysis of cell aggregates using Image J Software.

Anchorage independent growth assay

To measure anchorage independent growth, the soft agar assay was utilized. The assay consists of two layers: the bottom layer consisting of 1% low melting temperature agarose in a 1:1 ratio with DMEM with 10% FBS and the bottom layer being 0.6% noble agar mixed 1:1 with the cell solution. The top layer is added only after the bottom layer has fully solidified. 6 well plates were used and were cultured for 14 days with extra DMEM media being added every 2 days to ensure cell viability and to prevent the agar from drying. A 4 X objective from an Olympus IX73 microscope was used to image the assay. Image J Software was used to quantify the area and number of the colonies.

Cell migration and cell invasion assays

BD Falcon cell chambers (BD biosciences, CA, USA) were employed to evaluate cell migration. 2.5 X 104 cells in 500 μL serum free DMEM were added to each transwell insert without matrigel. 500 μL NIH-3T3 conditioned media was added to the lower chambers and cells were cultured for 20 h at 37°. BD Falcon Matrigel invasion chambers (BD biosciences, CA, USA) were used to measure cell invasion following the manufacturer’s instruction and with modifications as described [18]. For both assays, samples were done in quadruplet for 2 experiments. Membranes without and with Matrigel were removed from inserts, and then washed, fixed with 100% methanol, and stained with 1% Toluidine blue. Each membrane containing cells were counted using a Nikon TMS microscope. An Olympus IX73 was used to image the cells, to determine the number of either migratory or invasive cells per well.

3D Spheroid cell formation, growth and morphology

Uniform spheroids were used for 3D cell culture of the various NB cell lines. Medium (0.5 mL) was added to the 3D wells of Sphericalplate 5D plates (Kugelmeiers, Erlenbach, Sweden), followed by a 3 min 500 x g spin to eliminate potential air bubbles in the 3D wells. Cells (7.5 X 104 cells/mL) were added to each prepared 3D well, and subsequently the plate was lightly tapped to evenly distribute the cells. DMEM medium was added every 2–3 days to ensure cell viability and health. All spheroids were cultured in this manner to produce consistent spheroid cells. Images were taken at days 1, 4, 6, 7, and 9 using an Olympus IX71 microscope’s 10X objective to allow for the quantification of the size of the spheroid cells with Image J Software. Spheroid cells cultured for 7 days were also imaged with a 40X objective to measure the diameters of peripheral cells to compare cell morphology. Peripheral Cells that were overlapping another cell, or in cases where there was no clear border to define the individual cell, were excluded from the analysis.

Spheroid cell invasion assay

Cells were cultured for 1, 4 and 6 days in Sphericalplate 5D plates to form various size spheroids. Spheroid cells were collected from the 5D plates by placing them in a 15 mL centrifuge tube and allowed to settle for 10 minutes at room temperature. The suspended spheroid cells (40 μL) were then combined with Matrigel (200 μL). Spheroid/Matrigel mixture (40 μL) was pipetted into the center of the wells of a 24-well plate (4 wells per cell line) via pre-chilled pipet tips. Matrigel was polymerized by incubation at 37° for 30 minutes and then media (1 mL) was added to culture cells for 16 h or 24 h. Acquisition and analysis was similar to that previously described [22]. A 4X objective on an Olympus IX73 microscope was used to capture images. ImageJ software was utilized to measure the sphere and invasive areas. Cell invasion is reported as the ratio of the invasion area to the sphere area.

Coomassie blue stained gels and western blotting

Total cell membrane, concentrated conditioned serum-free media, and whole cell lysate samples were evaluated by coomassie blue stained electrophoreses gels and western blotting [18]. Proteins were electrophoresed on 10% SDS gels and stained with coomassie blue to evaluate total protein levels. For Western blotting, PVDF membranes (Millipore, Billercia, MA, USA) containing separated proteins on 10% SDS gels were incubated with primary and secondary antibodies and then visualized using NBT/BCIP. The primary antibodies include the following: rabbit anti-palladin antibody (Proteintech, Rosemont, IL), rabbit anti-EGFR (Cell Signaling Tech, Danvers, MA), rabbit anti-hexokinse 2 (Abcam, Cambridge, MA), and rabbit anti-vimentin (Cell Signaling Tech, Danvers, MA).

Gelatin zymography assay

Proteins of non-reduced conditioned serum-free media samples were separated on 10% SDS acrylamide gels, plus 4 mg/mL gelatin at 20 mA for 1.5 h. Gels with electrophoresed proteins were washed twice with washing buffer (2.5% Triton X-100, 50 mM Tris-HCL, pH 7.5, 5 mM CaCl2, 1 μM ZnCl2) for 30 minutes, and then rinsed in incubation buffer (1% Triton X-100, 50 mM Tris-HCL, pH 7.5, 5 mM CaCl2, 1 μM ZnCl2) for 5–10 minutes with gentle agitation at 37°C. The gel was then incubated in fresh buffer at 37°C with slight agitation. After 24 h, the gel was stained with Coomassie Blue and bands were visualized by incubation of gel in a destaining solution.

Data analysis

Image J software was employed for data analysis, including measurements of individual cells, cell aggregates, spheroid cells, and spheroid invasion. Adobe Photoshop was employed for microscopic images, gelatin gels and western blot images. Origin 9.55 was used for graphics and statistics. UN-SCAN-IT and image J softwares were employed to determine total intensity, and the relative size and darkness of a given band, respectively. Data is presented as the mean S.E. where n denotes the number of observations, as indicated. Statistical comparison of two groups were accomplished using student’s t-test while one-way ANOVA with Bonferroni adjustments was used for more than two groups while the unpaired student’s t-test was used for comparing mean values, unless indicated.

Results

Using CRISPR/Cas9 technology, the Mgat1 (GnT-I) gene was silenced in NB_1 cells, the parental cell line, and was named the NB_1(-Mgat1) cell line. The parental cell line, NB_1, has GnT-I and GnT-II, and therefore has all three types of N-glycans while the N-glycosylation mutant cell line, NB_1(-Mgat1) has only oligomannose N-glycans (Fig 1A). DNA sequencing of 9 recombinant vectors that encoded a fragment of the Mgat1 gene showed that 6 Mgat1 DNA fragments had a G residue inserted after the 54th nucleotide residue while 3 others had nucleotide 54 removed (Fig 1B). Both indels produced frameshift mutations with an alternative start site at amino acid residue 251. To examine whether the N-glycans were changed in the N-glycosylation mutant cell line, as expected from silencing the Mgat1 gene, we compared lectin binding studies of the NB_1(-Mgat1) cell line to the parental (NB_1) cell line. Further we examined whether NB_1(-Mgat1) cells transiently expressing Mgat1, referred to as NB_1(-/+Mgat1) cells, produced more processed N-glycan structures, such as hybrid and complex types. The rescue would support changes in N-glycan structures of the NB_1(-Mgat1) cell line was due to silencing of the Mgat1 gene, and not an off-target gene. Fluorescent-labelled lectins were allowed to interact with live NB_1(-Mgat1) or NB_1 cells, and then fluorescence intensity in various cell samples were measured by flow cytometry as viewed in the representative histograms (Fig 1C), and mean fluorescence intensity of each of lectins for both cell lines determined (Fig 1D). Markedly greater amounts of Phaseolus vulgaris Erythoagglutinin (E-PHA), a lectin with very high affinity for complex type N-glycans with bisecting N-acetylglucosamine (GlcNAc) relative to other N-glycan structures [23], bound to parental cells than N-glycosylation mutant cells. Phaseolus vulgaris Leucoagglutinin (L-PHA), which has much higher affinity for complex type N-glycans than hybrid and oligomannose types [23], bound to parental cells at a higher level than that of N-glycosylation mutant cells. More Galanthus nivalis Lectin (GNL) and concanavalin A (ConA) bound to the N-glycosylation mutant cells than parental cells. Both lectins have higher affinities to oligomannose type of N-glycans than other types [23, 24]. Predominant types of N-glycans identified by flow cytometry were verified by lectin blotting of whole cell lysates from NB_1 and NB_1(-Mgat1) cell lines (Fig 1E). The GNL interaction was detected much more strongly with proteins from NB_1(-Mgat1) relative to those from NB_1. On the other hand, the E-PHA interaction was observed more strongly with proteins from the NB_1 cell line than those from the NB_1(-Mgat1) cell line. Further the detected interaction of GNL and E-PHA with separated proteins from NB_1(-Mgat1) cells transfected with Mgat1 was diminished and improved, respectively, compared to those from the NB_1(-Mgat1) cell line. The Coomassie blue stained gel confirmed the levels of protein loaded per well for the lectin blots were quite similar in various cell lines. Overall, the lectin binding studies confirmed that the NB_1 cell line expressed the mature N-glycans type, complex, and had significant levels of bisecting type N-glycans [19, 20] while the NB_1(-Mgat1) cell line had oligomannose type. Further when NB_1(-Mgat1) cells were transfected with Mgat1 they were observed to produce higher branched N-glycans, indicating that the changes in the N-glycan structures were due to silencing Mgat1 in the glycosylation mutant cell line.

Fig 1. Characterization of a neuroblastoma cell line with knockout of GnT-I.

Fig 1

(A) The simplest N-glycan is oligomannose which gives rise to more mature N-glycans, hybrid and complex. GnT-I converts oligomannose to hybrid, and subsequently GnT-II converts hybrid to complex. (B) The coding sequence of rat Mgat1 from 25 to 66 was compared to that isolated from a newly created NB_1(-Mgat1) cell line. Two frameshift mutations were identified, including an inserted g nucleotide and a deletion of a g nucleotide as indicated in bold red font and dash line, respectively. Further the next in-frame start codon does not occur until residue 251 (C) Typical flow cytometry plots of NB_1 (top panels), and NB_1(-Mgat1) (bottom panels) cell lines interacting with fluorescently labelled lectins. (D) Mean fluorescence intensity of E-PHA (n = 5), L-PHA (n = 5), GNL (n = 5) and ConA (n≥2) bound to NB_1 and NB_1 (-Mgat1) cells. Graph denotes mean ± SEM and were compared by student’s t-test (*p < 0.01). (E) Lectin blots and a coomassie blue stained gel of proteins from whole cell lysates of NB_1 and NB_1(-Mgat1) cell lines. Vertical dotted and solid lines denote gel lane dividers and a different gel, respectively. Molecular weight standards (STD) in kDa: 250; 150; 100; 75; 50; and 37 from top to bottom.

Morphology of individual and spheroid NB cells with modifications in the N-glycosylation pathway

To examine whether changing N-glycan types alters NB cell morphology, the NB_1 and NB_1(-Mgat1) cell lines were employed to evaluate the impact of complex and oligomannose types of the N-glycans. Previously, we showed that neurites were shortened when comparing NB cells expressing hybrid versus complex types of N-glycans [20]. Images of individual cells were captured (Fig 2A) and the length (Fig 2B) and width (Fig 2C) of neurites were measured in NB_1 and NB_1(-Mgat1) cells. Images revealed rounder cells with shortened neurites of the mutant cell line. The length of the neurites was reduced by about 70% while the width of the neurites was increased by 1.3-fold for NB_1(-Mgat1) relative to NB_1 cells. Morphological studies of spheroid cells were used to ape the environment of cells in a multicellular organism. Micrographs were obtained from spheroid cells cultured for 7 days from NB_1, NB_1(-Mgat2), and NB_1(-Mgat1) cell lines (Fig 2D). The NB_1(-Mgat2) cell line was employed to address morphological changes of spheroid NB cells expressing significant levels of hybrid type N-glycans [19, 20]. Parental cells formed larger spheroids than the N-glycosylation mutant cells lines (Fig 2E). Further the mutant cell line that could synthesize oligomannose and hybrid types of N-glycans formed larger spheroid cells than those that could solely synthesize oligomannose type of N-glycans. Images also revealed that cells at the edge of the spheroids, as denoted by the blue arrows, were larger for cell lines that formed larger spheroids (Fig 2F). Thus, neurite formation in the 2D cell cultures and spheroid cell formation of the 3D cultures were lessened when the N-glycosylation pathway was prevented from synthesizing higher ordered N-glycans.

Fig 2. Morphology of NB cells and NB spheroids are dependent on the type of N-glycan.

Fig 2

(A) Representative images of NB_1 and NB_(-Mgat1) cells from 2D cell cultures. Length (B) and width (C) of neurites from cells grown in 2D cell cultures. (D) Typical images of 7 days old spheroids obtained at 40x magnification. Blue arrowhead depicts measured cells at outer edge of sphere. (E) Quantification of spheroid size determined from images obtained at 10x magnification. (F) Diameter of cells at outer edge of sphere were quantified. Scale bars are 25 μm. Data are presented as the mean±SEM and were compared by one-way ANOVA followed by Holm-Bonferroni adjustment (*p < 0.02, **p<0.001). n denotes the number of neurites, cell diameters or spheroids measured, respectively.

Cell proliferation and growth of 2D and 3D cell cultures with interruptions in the N-glycosylation pathway

Cell proliferation was measured in 2D sub-confluent cell cultures by incorporation of BrdU into the DNA during its replication process (Fig 3A). There was about a 54% decrease in cell proliferation between NB_1(-Mgat1) cells and NB_1 cells. When NB_1(-Mgat1) cells were transient transfected with Mgat1 cDNA, cell proliferation was increased to near 80%. The rescued cells, NB_1(-/+Mgat1), indicated that the slowed cell proliferation in NB_1(-Mgat1) cells was due to silencing the Mgat1 gene. As such, higher ordered N-glycans enhanced the cell proliferation rate of NB cells. Cell growth was monitored under 3D cell cultured conditions. Images of cell colony size under anchorage independent cell growth conditions for 13 days were reduced in the glycosylation mutant cell line compared to the parental cell line (Fig 3B). Quantification of cell colony area between NB_1 and NB_1(-Mgat1) cell lines revealed close to a 52% difference in cell growth (Fig 3C). Lastly, cell growth was observed at 1, 4, 6, 7 and 9 days for NB_1, NB_1(-Mgat1) and NB_1(-Mgat2) cell lines using 5D spherical plates (Fig 3D). Spheroid cell size of NB_1 and NB_1(-Mgat1) cell lines were similar up to 6 days while the spheroids of NB_1(-Mgat2) cells were slightly smaller (Fig 3E). Though the spheroid size of NB_1(-Mgat2) cells was larger than that of NB_1(-Mgat1) cells at day 7 and also the spheroid from NB_1 cells continued to be the largest. The growth rates were (in spheroid area/days): 10,130, NB_1; 6,625, NB_1(Mgat2); and 6,036, NB_1(Mgat1). However, it took close to 9 days of spheroid growth for NB_1 cells to establish a 2-fold difference in spheroid size relative to either of the glycosylation mutant cells. The growth of the spheroid cells from 1 to 9 days displayed high linearity as Pearson’s correlation coefficients were the following: NB_1, 0.95; NB_1(-Mgat2), 0.97; and NB_(-Mgat1), 0.98. Taken together, lessened cell growth caused by preventing the synthesis of complex and hybrid types of N-glycans in 2D and 3D cell cultures was a common trend. However, it should be noted that cell growth was hampered to a greater extent in 3D cell cultures than 2D cell cultures.

Fig 3. Diminution of N-glycan diversity alters NB cell growth and spheroid formation.

Fig 3

(A) Cell proliferation of NB_1 and NB_(-Mgat1) cell lines from 2D cell cultures, and the rescued cell line, NB_(-/+Mgat1). (B) Images of growing cell colonies obtained from anchorage independent cell growth of NB_1 and NB_(-Mgat1) cell lines. (C) Quantification of the size of cell colonies after 13 days of growth. (D) Representative images of spheroid formation in NB cell lines at various time points were obtained at 10x magnification. (E) Quantification of spheroid growth from 1 to 9 days in culture. Pearson’s correlation coefficient of the spheroid area as a function of days for NB_1, NB_1(-Mgat2) and NB_(-Mgat1) were 0.99, 0.99, and 0.94, respectively. Growth rates were (in area/days): 10,130, NB_1; 6,625, NB_1(-Mgat2); and 6,036, NB_1(-Mgat1). Scale bars are 25 μm. Data are presented as the mean±SEM and were compared by one-way ANOVA followed by Bonholm adjustment for more than 2 groups and student t-test for 2 groups, (*p < 0.05, **p<0.005, ***p<1 x10-6). n signifies number of wells (A), cell clusters (C), and spheroids (E).

Cell migratory rates were relatively constant for NB cell lines with different types of N-glycans

Cell chambers were divided into upper and lower chambers using membrane inserts. A low density of cells from monolayer suspensions were placed on top of membrane inserts to produce a 2D sub-confluent cell culture. Conditioned medium from NIH3T3 cell cultures was placed in bottom chambers to attract cells to migrate from top to bottom chambers. After a 20 h incubation, membrane inserts were collected, washed, and mounted on microscope slides, and then images of the membranes bottom-side were acquired. Micrographs showed that similar numbers of NB_1, and NB_1(-Mgat1) cells migrated to the bottom chamber (Fig 4A). Further cell migration was unaltered in the later cell line with transient expression of GnT-I. Quantification of the number of migratory cells from each cell line demonstrate the reproducibility of our observations (Fig 4B). These results indicate that the migratory rates in NB cells was unaltered by disrupting the N-glycosylation pathway.

Fig 4. Substitution of complex with oligomannose types of N-glycans on cell migration and invasion of sparse cells.

Fig 4

(A) Represented images of migratory parental and glycosylation mutant NB cells from the bottom of the membrane insert contained in transwell chambers after 20 h incubation, as indicated. (B) Quantification of the number of migratory cells that crossed the membrane insert per well. (C) Selected micrographs of invading parental and glycosylation mutant NB cells from Matrigel invasion chambers following a 20 h incubation period. (D) Average number of invasive cells per well. Bright purple migratory and invasive cells and pores in membrane are visible. Data are presented as the mean±SEM and were compared by one-way ANOVA using Holm-Bonferroni test (*p < 0.005). n denotes number of wells examined.

Cell invasiveness was lessened by decreased levels of complex type N-glycans in 2D NB cell cultures

Since cell migratory rates were unchanged in the various NB cell lines, similar cell chambers were used to directly assess cell invasiveness, except membrane inserts were layered with an extracellular matrix (Matrigel®). Again, addition of conditioned medium from NIH3T3 cell cultures to the bottom chamber was used to encourage cells to migrate to the bottom cell chamber but to get there they had to digest the matrigel. Representative images showed that there were more NB_1 cells than NB_1(-Mgat1) cells on the bottom-side of the membrane insert, and that expression of GnT-I in the latter cell line called NB(-/+Mgat1) increased invasive cell number (Fig 4C). The average number of invasive cells from each of the cell lines show that the NB_1 cell line was most invasive while the NB_1(-Mgat1) cell line was least invasive (Fig 4D). Cell invasiveness of NB_1(-Mgat1) was about 36% of NB_1, and when NB_1(-Mgat1) cells were transfected with Mgat1, the cells were more invasive, such that NB_1(-/+Mgat1) cells were about 76% of NB_1 cells. Thus, these results reveal that the decrease in cell invasiveness was due to preventing the conversion of oligomannose to complex types of N-glycans in 2D sub-confluent cell cultures.

Cell invasiveness was intensified by lowered levels of complex type N-glycans in 3D NB cell cultures

Since a cancerous mass is a cluster of cells, we conducted cell invasion studies using spheroid cells. Spheroids were formed for 24 h in 5D spherical plates and added to cell dishes in a Matrigel slurry. After 24 h, images of the spheroids were obtained for NB_1, NB_1(-Mgat2) and NB_1(-Mgat1) cell lines (Fig 5A). Images revealed that NB_1(-Mgat1) cells had more and longer protrusions than the other types of cells, indicating that the glycosylation mutant cells solely expressing oligomannose type N-glycans were more invasive than those expressing hybrid or complex types of N-glycans. To quantify cell invasiveness, the ratio of measured invasive area to the measured sphere area was determined as shown in Fig 5B. The cell invasiveness of the NB_1(-Mgat1) cell line was 2.3-fold greater than the NB_1 cell line and 3-fold greater than the NB_1(-Mgat2) cell line (Fig 5C). The Pearson’s correlation coefficients were greater than 0.69 for each cell line (Fig 5D). In all cases, cell invasion was dependent on sphere area. Further, oligomannose type N-glycans promoted cell invasiveness relative to higher order N-glycans, such as hybrid and complex types.

Fig 5. Disruption in the N-glycosylation pathway modifies 3D cell invasion.

Fig 5

(A) Images of representative cell invasiveness from 1-day old spheroids of parental and N-glycosylation mutant cell lines cultured for 24 h in Matrigel matrix. (B) Micrograph of invading spheroid cells indicating measured sphere and invasive areas. Scale bars represent 25 μm. (C) The ratio of the invasion area to the sphere area were determined and plotted for NB_1 (n = 22), NB_1(-Mgat2) (n = 15) and NB_1(-Mgat1) (n = 18) cell lines. (D) Pearson’s correlation coefficients from plots of sphere area versus invasion area for each cell line. Data are presented as the mean±SEM and were compared by one-way ANOVA using Holm-Bonferroni test (*p < 0.05). n denotes number of spheroids measured.

Next, we addressed cell invasiveness due to different spheroid size and invasion incubation period of the various NB cell lines. Spheroid NB cells were grown for longer periods of time in 5D spherical plates and then cultured in a Matrigel slurry for 16 (panels A & B) or 24 hours (panel C) (Fig 6). The longer growth period allowed examination of cell invasiveness for larger spheroid cells of the various cell lines. It was observed that the NB_1(-Mgat1) cell line was more invasive at 4 (panel A) and 6 (panel B) days old spheroid cells than those of the NB_1 cell line. Further spheroid cells of NB_1(-Mgat2) were less invasive than the NB_1 cells. A similar trend was also observed when 6-day old spheroid cells invaded for 24 h (Fig 6C). Average cell invasion was about 2.1 for NB_1(-Mgat1) cells when spheroids cultured for 4 (Fig 6D) and 6 (Fig 6E) days invaded for 16 h while these values increased to close to 5.1 when 6 day old spheroids invaded for 24 h, respectively (Fig 6F). Increases were also measured for average cell invasion values for NB_1 and NB_1(-Mgat2) when the invasion time was increased from 18 h to 24 h. When comparing all 3D spheroid invasion assays, cell invasiveness was greatest in the NB_1(-Mgat1) cell line, intermediate for the NB_1 cell line and least in the NB_1(-Mgat2) cell line. Based on Pearson’s correlation coefficeints, cell invasion area was dependent on sphere area for all three cell lines. Hence, cell invasiveness was modified by altering the N-glycosylation pathway in NB cells.

Fig 6. NB cell invasion is independent of spheroid cell size and dependent on incubation period of spheroid cells.

Fig 6

Characteristic images of invading spheroid cells from those cultured for 4 (A) and 6 (B) days of NB_1 (n = 45 and 43), NB_1(-Mgat2) (n = 49 and 26) and NB_1(-Mgat1) (n = 59 and 48) cell lines and incubated in Matrigel matrix for 16 h duration, and spheroid cells cultured for 6 days (C) and incubated in Matrigel matrix for 24 h duration of NB_1 (n = 21), NB_1(-Mgat2) (n = 23) and NB_1(-Mgat1) (n = 20) cell lines. Scale bar denotes 25 μm. Quantification of cell invasiveness of the various cell lines in which spheroids were cultured for 4 (D) and 6 (E and F) days and incubated in Matrigel matrix for 16 (D and E) and 24 (F) hours. Data are shown as the mean±SEM and were compared by one-way ANOVA using Holm-Bonferroni post-hoc test (*p < 0.05). n denotes number of invading spheroids. Pearson’s correlation coefficient determined from sphere area versus invasion area were the following: NB_1, 0.69; NB_1(-Mgat2), 0.65; NB_1(-Mgat1), 0.75 from 4 day old spheroid allowed to invade for 16 h. Pearson’s correlation coefficients for the following: NB_1, 0.57; NB_1(-Mgat2), 0.62; NB_1(-Mgat1), 0.51, and NB_1, 0.68; NB_1(-Mgat2), 0.51; NB_1(-Mgat1), 0.79 from 6 day old spheroid allowed to invade for 16 h and 24 h, respectively.

MMP activities are altered by changes in the N-glycosylation pathway in both 2D and 3D cultures

Gelatin zymography of concentrated conditioned serum-free media of 2D cell cultures from NB_1, NB_1(-Mgat1) and NB_1(-Mgat2) cell lines revealed 3 intense bands of gelatinase activity at about 110 kDa (black arrow), 90 kDa (grey arrow), and 65 kDa (black arrow) (Fig 7A). The coomassie blue stained gel of identical loads indicate that similar amounts of protein were loaded. The upper band had greatest gelatinase activity in the NB_1(-Mgat1) cell line while the NB_1 and NB_1(-Mgat2) cell lines had comparable levels (Fig 7B). The middle band was most intense for NB_1, intermediate lightness for NB_1(-Mgat2) and least intense for NB_1(-Mgat1). For the lower band, both NB_1 and NB_1(-Mgat2) had similar band intensity while that of NB_1(-Mgat1) was lower. It appears that NB_1 cells have higher gelatinase activity than the N-glycosylation mutant cell lines under 2D cell culturing conditions. Evaluation of the 3D samples by the gelatinase assay showed 2 intense bands of gelatinase activity at 90 kDa and 65 kDa (Fig 7C). Similar levels of proteins were loaded as shown in the coomassie blue stained gel. The lightness of both bands was highest for the NB_1(-Mgat1) sample while the lightness of the bands of the NB_1(-Mgat2) sample was quite like NB_1 (Fig 7D). Gelatinase activities were greater in the 3D cell cultures than 2D cultures as the amount of protein loaded for the 2D gel was close to 2-fold greater. Taken together, the results showed that the NB_1 cells have higher gelatinase activity than the N-glycosylation mutant cell lines under 2D cell culturing conditions while the gelatinase activity was highest for the NB_1(Mgat1) cells grown under 3D conditions.

Fig 7. Gelatinase activity of 2D and 3D NB cell cultures.

Fig 7

Gel zymography of conditioned serum-free medium samples from confluent plates (A) and spheroids cells (C) of NB_1, NB_1(-Mgat1) and NB_1(-Mgat2) cell lines (left panels). The amount loaded per well for 2D and 3D samples were 12 μg and 3 μg per well, respectively. Coomassie blue stained gels (right panels) of conditioned samples (10 μg) were loaded per well. Black arrows adjacent to gels denote upper and lower bands while grey arrow signifies middle (Mid) band. Numbers adjacent to gels denote molecular markers. Bands from glycosylation mutant samples were normalized to those NB_1 for 2D (B) and 3D (D) cell cultures. Data are shown as the mean±SEM and were compared by one-way ANOVA using Holm-Bonferroni post-hoc test (*p < 0.05). n = 3 for upper, middle and lower bands from the various samples.

N-glycan types modify cell-cell adhesion strength in cellular monolayers and spheroid cells

The strength of cell-cell adhesion of NB_1(-Mgat1) cells was compared to that of NB_1 cells by breaking up detached cell monolayers. Representative images show that size of cell monolayer fragments from glycosylation mutant cells were larger than those from parental cells (Fig 8A). Further transfection of NB_1(-Mgat1) cells with the Mgat1 gene reduced the size of the cell clusters. Mean cell cluster area was increased in NB cells by at least 1.7-fold when Gn-TI was knocked down and knock in of Gn-TI in some of the NB_1(-Mgat1) cells reduced the size to about 1.4-fold (Fig 8B). These results showed that lowered levels of complex and hybrid N-glycans strengthened the cell-cell interaction in monolayer NB cells.

Fig 8. Modification of expression levels of Mgat1 impact cell-cell adhesion.

Fig 8

(A) Selected DIC images obtained from NB_1 (left panels), NB_1(-Mgat1) (middle panels), and NB_1(-/+MGAT1) (right panels) cell lines. Cell aggregates of more than 5 cells, as encircled in white, were analyzed. (B) The average area of cell aggregates from 3 cell dissociation experiments for each cell line. *P<0.01. Mean differences were compared using One-way ANOVA followed by Holmes-Bonferroni’s test was used to compare differences in mean values. A value of P<0.00000001 was considered significant (*). n signifies number of cell clusters.

Palladin, vimentin and EGFR levels are changed by N-glycan types and 3D cultured cells

Western blotting was conducted to measure the protein abundance of HK2, palladin and vimentin in whole cell lysate samples of 2D and 3D cultures, along with EGFR in total membrane samples from both types of cultures (Fig 9A). Total protein levels were comparable for the whole cell lysate or total membrane samples from 2D or 3D cultures as shown in the coomassie blue stained gel (Fig 9B). Both palladin (NB1, 62±4%, n = 3; NB_1(-Mgat2), 73±10%, n = 3; and NB_1(-Mgat1), 59±8%, n = 3) and HK2 (NB1, 53±9%, n = 3; NB_1(-Mgat2), 48±10%, n = 3; and NB_1(-Mgat1), 49±5%, n = 3) protein levels were reduced in 2D cultures relative to those of 3D while vimentin and EGFR levels appeared similar between the culturing conditions. When Mgat1 or Mgat2 were silenced in the NB_1 cell line, the abundance of palladin was lowered, and significantly lowered in the NB_1(-Mgat2) compared to the NB_1(-Mgat1) in 2D cell cultures (Fig 9C). The abundances of HK2 and EGFR proteins were unchanged by altering the glycosylation pathway in 2D cultures. Vimentin level of the NB_1(-Mgat2) cell line was markedly lowered than that of the NB_1 cell line, and furthermore reduced to about 40% of the NB_1(-Mgat1) cell line in 2D cultures. In 3D cell cultures, the level of palladin was lowered when either Mgat1 or Mgat2 genes were silenced in NB_1, and palladin was also significantly lowered in the NB_1(-Mgat1) cell line compared to that of the NB_1(-Mgat2) cell line (Fig 9D). The level of HK2 was unaltered in 3D cultures. The abundance of vimentin in NB_1(-Mgat1) was significantly higher than that from NB_1(-Mgat2) while the later was quite like that of NB_1. EGFR levels were significantly lower for NB_1(-Mgat1) relative to NB_1(-Mgat2), which was like that of NB_1. Thus, proteins involved in cell morphology, growth and invasion appear to be changed under different growth conditions and by modifications in the N-glycosylation pathway.

Fig 9. Palladin, vimentin and EGFR levels were altered by changes in the N-glycosylation pathway.

Fig 9

(A) Western blots of HK2, palladin, and vimentin in whole cell lysates (WCL), and EGFR in total membranes (TM) from 2D and 3D cell cultures. Number adjacent to blot represents molecular weight marker in kDa. Arrows point to immunobands of interest. Protein levels loaded per well for detection of vimentin, EGFR and HK2 in both 2D and 3D samples were 20 μg per well while those for palladin were 20 μg and 10 μg for 2D and 3D samples, respectively. Blot of palladin has molecular weight markers of 75 and 100 kDa in the center lane while that of EGFR has the 150 kDa marker. Standards were not removed to show 2D and 3D samples were run on same gel and blots developed in a similar manner. (B) Coomassie blue stained gels of whole cell lysates and total membranes from 2D (20 μg) and 3D (20 μg) cell cultures. Molecular weight standards (STD) in kDa: 250; 150; 100; and 75 from top to bottom. Immunobands from NB_1(-Mgat2) and NB_1(-Mgat1) cell lines were normalized to those from the NB_1 cell line from 2D (C) and 3D (D) cultures. Data are represented as the mean±SEM and were compared by student’s T-test (*p < 0.05). n values were 3 where n represents a band.

Discussion

This study showed that knockdown of the GnT-I in NB cells modified cell morphology, growth, adhesion, and invasion, along with expression patterns of MMPs, HK2, EGFR, vimentin, and palladin proteins in 2D cell cultures. When comparing these cellular processes and protein levels of the parental cell line (NB_1) to cell lines with the N-glycosylation pathway interrupted (NB_1(-Mgat1) and NB_1(-Mgat2)) under 3D cell cultured conditions, they were quite different from those under 2D conditions. Previously, we demonstrated that NB_1 [19] and NB_1(-Mgat2) [19, 20] cells expressed significant levels of complex and hybrid types N-glycans, respectively. Here, lectin binding studies supported that NB_1(-Mgat1) cells predominantly expressed oligomannose type N-glycans. Further higher order N-glycans could be restored by transiently transfecting NB_1(-Mgat1) cells with mouse Mgat1. Taken together, different types of N-glycan populations favored different aberrant cellular properties and were dependent on whether the NB cells were cultured under 2D or 3D conditions. Emphasizing tumor microenvironment on cell growth and invasiveness.

Unexpectedly, cell invasiveness was different between 2D cultures of dispersed cells versus 3D cultures of spheroid cells, consisting of small, intermediate, and large size spheroids. Previously, we showed that the NB cell line with complex type N-glycans was more invasive than NB cells expressing more hybrid type N-glycans [18, 20]. Additionally, 2D cell culture studies demonstrated that complex N-glycans with β1,6-branches, along with a decline in hybrid type N-glycans, were detected in cells derived from high risk neuroblastoma (NLF) compared to cells derived from low risk neuroblastoma (SY5Y) [25]. Our current 2D cell culture study shared similarities to these results, and also, showed that NB cells with less processed type of N-glycans (oligomannose) were even less invasive. On the contrary, the NB cell line predominantly expressing oligomannose type N-glycans was more invasive than NB_1 and much more invasive than NB_1(-Mgat2) under 3D culture conditions. Sphere area measurements support that cell invasiveness was dependent on size. As expected, longer growth of the spheroids in matrigel increased cell invasiveness. Although spheroid size at 1, 4 and 6 days of culturing are relatively similar for NB_1 and NB_1(-Mgat1), the sphere area used for analysis was smaller for the latter. In general, the larger spheroids from the NB_1(-Mgat1) cell line were omitted since their protrusions from the spheroid would attach to the bottom of the plate causing attached cells to readily spread. Again, reinforcing the relative great cell invasiveness of NB_1(-Mgat1) cells. Based on our 3D cell invasion studies, NB cells expressing complex N-glycans were less invasive than those expressing exclusively oligomannose. As such, our current results support a past clinical NB study which showed that GnT-V, the enzyme which initiates β1,6-branchpoints, was of higher abundance in favorable stages (1, 2 and 4s) than unfavorable stages (3 and 4) of NB [26]. Thus, it would be of great interest to evaluate whether unfavorable NB patients have lowered expression of GnT-I in tumor tissues compared to those with favorable NB. Further the cell culturing technique appears to have a major impact on interpreting cell invasiveness of NB cells.

A critical aspect of cell invasion is remodeling of the ECM which is carried out by the matrix metalloproteinase (MMP) family [27]. Under 2D cell culturing conditions, 3 gelatinase activities were identified when cells were cultured at least 72 h. Previously, we showed the lower band was MMP2 and was more abundant in the more invasive NB_1 cells than NB_1(-Mgat2) cells when cultured for 48 h [18]. The current study verifies higher MMP activities in the more invasive cell line, NB_1, than NB_1(-Mgat2) at the later timepoint, however, the patterns of MMP activity were different. Additionally, the activity appeared lowest in the least invasive cell line, NB_1(-Mgat1). When 3D cell cultures were examined two of the three MMP activities observed in 2D cell cultures were identified and both activity bands were most intense in NB_1(-Mgat1) cells. These results supported higher expression of MMPs in the more invasive cell lines. Previously, we suggested that NB_1(-Mgat2) cells may have lower MMP levels due ER stress caused by a build-up of N-glycosylated proteins in the ER of 2D cultures [18] since anti-cancer compounds have correlated ER stress with lower MMP levels [28, 29]. However, our current study which reveals higher cell invasiveness and abundance of MMP activities of NB_1(-Mgat1) cells under 3D culturing conditions opposes this explanation.

Cell morphology differs in 2D and 3D cell cultures. When the N-glycosylation pathway was interrupted in NB cells by silencing Mgat1 (Fig 2A) or Mgat2 [18], cells rounded up and neurites were truncated relative to NB cells with an intact N-glycosylation pathway in 2D cultures. Expression levels of two cytoskeleton proteins, vimentin and palladin, were also altered in the N-glycosylation mutant cells relative to parental cells. Past studies have shown the roles of vimentin [30, 31] and palladin [13] in cell shape, and furthermore in lengthening of neurites of neurons. As such, the truncated neurites are likely due to reduced levels of palladin in 2D cell cultures of NB_1(-Mgat1) and both palladin and vimentin of NB_1(-Mgat2). It appears palladin has a stronger influence on neurite formation as vimentin levels in NB_1(-Mgat1) cells were similar to NB_1 cells. In 3D cultures, palladin and vimentin levels were reduced in NB_1(-Mgat2) while palladin levels declined and vimentin levels were raised in NB_1(-Mgat1) relative to those in NB_1. A notable difference in the morphology of cells in the outer region of spheroids was their diameter. The size of NB_1, NB_1(-Mgat2) and NB_1(-Mgat1) cells was largest, intermediate, and smallest, respectively. Interestingly, the size of cells at the edge of the spheroid correlated with the levels of palladin as this protein was lower in NB_1(-Mgat2) cells and lowest in NB_1(-Mgat1) cells relative to NB_1 cells. In comparing 2D versus 3D cultures, the level of palladin levels was higher in 3D. Taken together, our results support the role of palladin in neurite lengthening of 2D cultures, and furthermore supports novel roles of palladin in size of cells in the outer portion of the spheroid cells, and production of larger spheroid cells.

Cell growth occurred at a faster rate in NB cells with complex type N-glycans relative those without complex type N-glycans but this process was retarded in 3D cultures compared to 2D cultures. NB_ 1 and NB_1(-Mgat2) cell lines showed about a 2-fold difference in quantity of cells after 2 and 13 days under 2D and 3D conditions, respectively [18, 20]. The decrease in cell growth has been previously described for other cell lines [8]. Here a similar trend was shown in that a 2-fold difference between NB_1 and NB_1(-Mgat1) cells occurred in around 1 day in monolayer cell cultures while this difference took roughly 13 and 9 days in spheroid cell formation in agar versus in 5D spherical plates, respectively. Previously, cell growth of NB_ 1 and NB_1(-Mgat2) cell lines were similar to the cell proliferation rates in 2D cultures [20]. 2D cell culture involves cell-attached growth with cells having relatively equal exposure to media, while 3D cultured cells comprise of non-adhered cell aggregates with cells in the outer spheroid shell verses those in the inner core having maximal to minimal exposure to media [8]. Here, 5D sphericalplates were used for 3D cultures which have been shown to generate spheroids, lacking necrotic cores [32]. Additionally, protein expression of 3D versus 2D NB cultures are quite different, indicating the requirement of different cellular processes for their replication and viability [5]. Here the amount of HK2 levels was more abundant in 3D than 2D cell cultures which support the increased levels of other glycolytic enzymes, such as pyruvate kinase α-enolase, phosphoglycerate mutase 1 and triphosphate isomerase [5]. Thus, the difference in cell growth and the additional breakdown of glucose for energy between 2D and 3D cell cultures are likely supported by their growth requirements. Under 2D culturing, cell proliferation is the major factor affecting NB_1 cell growth while other processes are involved in the rate of cell growth under 3D conditions, such as ECM remodeling, transport, and cell adhesion.

EGFR, a receptor protein involved in cell proliferation and invasiveness, is known to be overexpressed in human neuroblastoma cells [16, 17]. Herein, we observed a decrease in cell proliferation when N-glycans were less processed, although EGFR levels remain unchanged under 2D culturing conditions. We suggest that the slowed cell proliferation could be due to truncated N-glycans as enhanced branching of the N-glycans attached to EGFR increased cell growth and proliferation under 2D conditions [33]. In 3D cell cultures, significantly lower levels of EGFR were detected in the N-glycosylation mutant cell line NB_1(-Mgat1) relative to NB_1 and NB_1(Mgat2) cell lines. However, spheroid cell growth between NB_1(Mgat2) and NB_1(Mgat1) was somewhat similar, suggesting additional processes and factors are involved in controlling cell growth.

We conclude, although the variables involved in neuroblastoma growth and progression are still poorly understood, engineered N-glycosylation mutant neuroblastoma (NB) cell lines provide a fundamental knowledge base as to the roles of various N-glycan types and their influence on NB development and prognosis, as well as potentially aid in development of additional treatment options. Based on our current 2D and 3D results of parental and N-glycosylation mutant NB cell lines, there are considerable differences in cellular processes, with emphasis on cell invasiveness and growth, and furthermore expression levels of cell growth proteins, cytoskeleton proteins and ECM digesting enzymes which likely support the value of 3D cell cultures in cancer research as they more closely mirror tumors in tissues.

Supporting information

S1 Raw images

(PDF)

S1 Data. Group data of Figs 19.

(XLSX)

Data Availability

All relevant data are within the manuscript and its supporting information files.

Funding Statement

This work was supported in part by National Institute of Health Grant GM129679 (to R.A.S.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.

References

  • 1.Ho WL, Hsu WM, Huang MC, Kadomatsu K, Nakagawara A. Protein glycosylation in cancers and its potential therapeutic applications in neuroblastoma. Journal of hematology & oncology. 2016;9(1):100. Epub 2016/11/01. doi: 10.1186/s13045-016-0334-6 ; PubMed Central PMCID: PMC5041531. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 2.Fuster MM, Esko JD. The sweet and sour of cancer: glycans as novel therapeutic targets. Nat Rev Cancer. 2005;5(7):526–42. Epub 2005/08/03. doi: 10.1038/nrc1649 . [DOI] [PubMed] [Google Scholar]
  • 3.Kamijo T, Nakagawara A. Molecular and genetic bases of neuroblastoma. International journal of clinical oncology. 2012;17(3):190–5. Epub 2012/05/17. doi: 10.1007/s10147-012-0415-7 [DOI] [PubMed] [Google Scholar]
  • 4.Stanley P, Taniguchi N, Aebi M. N-Glycans. In: Varki A, Cummings R, Esko J, Freeze H, Stanley P, Bertozzi C, et al., editors. Essentials of Glycobiology. 2nd ed. Cold Spring Harbor: Cold Spring Harbor Laboratory Press; 2009. p. Chapter 9. [PubMed] [Google Scholar]
  • 5.Kumar HR, Zhong X, Rescorla FJ, Hickey RJ, Malkas LH, Sandoval JA. Proteomic approaches in neuroblastoma: a complementary clinical platform for the future. Expert Rev Proteomics. 2009;6(4):387–94. Epub 2009/08/18. doi: 10.1586/epr.09.58 . [DOI] [PubMed] [Google Scholar]
  • 6.Freyer JP, Sutherland RM. Selective dissociation and characterization of cells from different regions of multicell tumor spheroids. Cancer Res. 1980;40(11):3956–65. Epub 1980/11/01. . [PubMed] [Google Scholar]
  • 7.Lottich SC, Johnston WW, Szpak CA, Delong ER, Thor A, Schlom J. Tumor-associated antigen TAG-72: correlation of expression in primary and metastatic breast carcinoma lesions. Breast Cancer Res Treat. 1985;6(1):49–56. Epub 1985/01/01. doi: 10.1007/BF01806010 . [DOI] [PubMed] [Google Scholar]
  • 8.Edmondson R, Broglie JJ, Adcock AF, Yang L. Three-dimensional cell culture systems and their applications in drug discovery and cell-based biosensors. Assay Drug Dev Technol. 2014;12(4):207–18. Epub 2014/05/17. doi: 10.1089/adt.2014.573 ; PubMed Central PMCID: PMC4026212. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 9.Li XY, Huang GH, Liu QK, Yang XT, Wang K, Luo WZ, et al. Porf-2 Inhibits Tumor Cell Migration Through the MMP-2/9 Signaling Pathway in Neuroblastoma and Glioma. Frontiers in oncology. 2020;10:975. Epub 2020/07/18. doi: 10.3389/fonc.2020.00975 ; PubMed Central PMCID: PMC7333564. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 10.Najm P, El-Sibai M. Palladin regulation of the actin structures needed for cancer invasion. Cell Adh Migr. 2014;8(1):29–35. Epub 2014/02/15. doi: 10.4161/cam.28024 ; PubMed Central PMCID: PMC3974790. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 11.Battaglia RA, Delic S, Herrmann H, Snider NT. Vimentin on the move: new developments in cell migration. F1000Res. 2018;7. Epub 2018/12/07. doi: 10.12688/f1000research.13350.2 ; PubMed Central PMCID: PMC6241562. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 12.Gialeli C, Theocharis AD, Karamanos NK. Roles of matrix metalloproteinases in cancer progression and their pharmacological targeting. Febs j. 2011;278(1):16–27. Epub 2010/11/20. doi: 10.1111/j.1742-4658.2010.07919.x . [DOI] [PubMed] [Google Scholar]
  • 13.Boukhelifa M, Parast MM, Valtschanoff JG, LaMantia AS, Meeker RB, Otey CA. A role for the cytoskeleton-associated protein palladin in neurite outgrowth. Mol Biol Cell. 2001;12(9):2721–9. Epub 2001/09/13. doi: 10.1091/mbc.12.9.2721 ; PubMed Central PMCID: PMC59707. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 14.Rogel MR, Soni PN, Troken JR, Sitikov A, Trejo HE, Ridge KM. Vimentin is sufficient and required for wound repair and remodeling in alveolar epithelial cells. Faseb j. 2011;25(11):3873–83. Epub 2011/08/02. doi: 10.1096/fj.10-170795 ; PubMed Central PMCID: PMC3205840. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 15.Altenberg B, Greulich KO. Genes of glycolysis are ubiquitously overexpressed in 24 cancer classes. Genomics. 2004;84(6):1014–20. Epub 2004/11/10. doi: 10.1016/j.ygeno.2004.08.010 . [DOI] [PubMed] [Google Scholar]
  • 16.Ho R, Minturn JE, Hishiki T, Zhao H, Wang Q, Cnaan A, et al. Proliferation of human neuroblastomas mediated by the epidermal growth factor receptor. Cancer Res. 2005;65(21):9868–75. Epub 2005/11/04. doi: 10.1158/0008-5472.CAN-04-2426 . [DOI] [PubMed] [Google Scholar]
  • 17.Zheng C, Shen R, Li K, Zheng N, Zong Y, Ye D, et al. Epidermal growth factor receptor is overexpressed in neuroblastoma tissues and cells. Acta biochimica et biophysica Sinica. 2016;48(8):762–7. Epub 2016/06/30. doi: 10.1093/abbs/gmw064 . [DOI] [PubMed] [Google Scholar]
  • 18.Hall MK, Whitman AA, Weidner DA, Schwalbe RA. Knockdown of N-Acetylglucosaminyltransferase-II Reduces Matrix Metalloproteinase 2 Activity and Suppresses Tumorigenicity in Neuroblastoma Cell Line. Biology (Basel). 2020;9(4). Epub 2020/04/09. doi: 10.3390/biology9040071 ; PubMed Central PMCID: PMC7236022. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 19.Hall MK, Weidner DA, Dayal S, Pak E, Murashov AK, Schwalbe RA. Membrane Distribution and Activity of a Neuronal Voltage-Gated K+ Channel is Modified by Replacement of Complex Type N-Glycans with Hybrid Type. Journal of glycobiology. 2017;6(3). Epub 2017/01/01. doi: 10.4172/2168-958X.1000128 ; PubMed Central PMCID: PMC6157612. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 20.Hall MK, Weidner DA, Whitman AA, Schwalbe RA. Lack of complex type N-glycans lessens aberrant neuronal properties. PLoS One. 2018;13(6):e0199202. Epub 2018/06/15. doi: 10.1371/journal.pone.0199202 ; PubMed Central PMCID: PMC6002081. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 21.Kumar R, Yang J, Larsen RD, Stanley P. Cloning and expression of N-acetylglucosaminyltransferase I, the medial Golgi transferase that initiates complex N-linked carbohydrate formation. Proc Natl Acad Sci U S A. 1990;87(24):9948–52. Epub 1990/12/01. doi: 10.1073/pnas.87.24.9948 ; PubMed Central PMCID: PMC55291. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 22.Berens EB, Holy JM, Riegel AT, Wellstein A. A Cancer Cell Spheroid Assay to Assess Invasion in a 3D Setting. Journal of visualized experiments: JoVE. 2015;(105). Epub 2015/12/10. doi: 10.3791/53409 ; PubMed Central PMCID: PMC4692745. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 23.Patnaik SK, Stanley P. Lectin-resistant CHO glycosylation mutants. Methods Enzymol. 2006;416:159–82. doi: 10.1016/S0076-6879(06)16011-5 . [DOI] [PubMed] [Google Scholar]
  • 24.Cummings R, Etzler M. Antibodies and Lectins in Glycan Analysis. In: Varki A, Cummings R, Esko J, Freeze H, Stanley P, Bertozzi C, et al., editors. Essentials of Glycobiology. 2nd ed. Cold Spring Harbor: Cold Spring Harbor Laboratory Press; 2009. p. Chapter 45. [PubMed] [Google Scholar]
  • 25.Hu Y, Mayampurath A, Khan S, Cohen JK, Mechref Y, Volchenboum SL. N-linked glycan profiling in neuroblastoma cell lines. J Proteome Res. 2015;14(5):2074–81. Epub 2015/03/03. doi: 10.1021/pr5011718 ; PubMed Central PMCID: PMC4516140. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 26.Inamori K, Gu J, Ohira M, Kawasaki A, Nakamura Y, Nakagawa T, et al. High expression of N-acetylglucosaminyltransferase V in favorable neuroblastomas: Involvement of its effect on apoptosis. FEBS Lett. 2006;580(2):627–32. doi: 10.1016/j.febslet.2005.12.089 . [DOI] [PubMed] [Google Scholar]
  • 27.Page-McCaw A, Ewald AJ, Werb Z. Matrix metalloproteinases and the regulation of tissue remodelling. Nat Rev Mol Cell Biol. 2007;8(3):221–33. Epub 2007/02/24. doi: 10.1038/nrm2125 ; PubMed Central PMCID: PMC2760082. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 28.Jiang Y, Jiao Y, Liu Y, Zhang M, Wang Z, Li Y, et al. Sinomenine Hydrochloride Inhibits the Metastasis of Human Glioblastoma Cells by Suppressing the Expression of Matrix Metalloproteinase-2/-9 and Reversing the Endogenous and Exogenous Epithelial-Mesenchymal Transition. Int J Mol Sci. 2018;19(3). Epub 2018/03/15. doi: 10.3390/ijms19030844 ; PubMed Central PMCID: PMC5877705. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 29.Xu XH, Liu QY, Li T, Liu JL, Chen X, Huang L, et al. Garcinone E induces apoptosis and inhibits migration and invasion in ovarian cancer cells. Sci Rep. 2017;7(1):10718. Epub 2017/09/08. doi: 10.1038/s41598-017-11417-4 ; PubMed Central PMCID: PMC5587559. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 30.Nakamura Y, Hashimoto R, Amano M, Nagata K, Matsumoto N, Goto H, et al. Localized phosphorylation of vimentin by rho-kinase in neuroblastoma N2a cells. Genes Cells. 2000;5(10):823–37. Epub 2000/10/13. doi: 10.1046/j.1365-2443.2000.00372.x . [DOI] [PubMed] [Google Scholar]
  • 31.Dubey M, Hoda S, Chan WK, Pimenta A, Ortiz DD, Shea TB. Reexpression of vimentin in differentiated neuroblastoma cells enhances elongation of axonal neurites. J Neurosci Res. 2004;78(2):245–9. Epub 2004/09/21. doi: 10.1002/jnr.20146 . [DOI] [PubMed] [Google Scholar]
  • 32.Wassmer CH, Bellofatto K, Perez L, Lavallard V, Cottet-Dumoulin D, Ljubicic S, et al. Engineering of Primary Pancreatic Islet Cell Spheroids for Three-dimensional Culture or Transplantation: A Methodological Comparative Study. Cell Transplant. 2020;29:963689720937292. Epub 2020/08/05. doi: 10.1177/0963689720937292 ; PubMed Central PMCID: PMC7563811. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 33.Lau KS, Partridge EA, Grigorian A, Silvescu CI, Reinhold VN, Demetriou M, et al. Complex N-glycan number and degree of branching cooperate to regulate cell proliferation and differentiation. Cell. 2007;129(1):123–34. doi: 10.1016/j.cell.2007.01.049 . [DOI] [PubMed] [Google Scholar]

Decision Letter 0

Salvatore V Pizzo

18 Sep 2021

PONE-D-21-18235Functional analysis of N-acetylglucosaminyltransferase-I knockdown in 2D and 3D neuroblastoma cell culturesPLOS ONE

Dear Dr. Schwalbe,

Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process. Please note the extensive comments from Reviewer No. 1.  If these issues can be addressed, it is likely that this manuscript will be accepted for publication.

Please submit your revised manuscript by Nov 02 2021 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.

Please include the following items when submitting your revised manuscript:

  • A rebuttal letter that responds to each point raised by the academic editor and reviewer(s). You should upload this letter as a separate file labeled 'Response to Reviewers'.

  • A marked-up copy of your manuscript that highlights changes made to the original version. You should upload this as a separate file labeled 'Revised Manuscript with Track Changes'.

  • An unmarked version of your revised paper without tracked changes. You should upload this as a separate file labeled 'Manuscript'

If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter.

If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols. Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols.

We look forward to receiving your revised manuscript.

Kind regards,

Salvatore V Pizzo

Academic Editor

PLOS ONE

Journal Requirements:

When submitting your revision, we need you to address these additional requirements.

1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at

https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and https://journals.plos.org/plosone/s/file?id=ba62/PLOSOne_formatting_sample_title_authors_affiliations.pdf.

2. We note that you have indicated that data from this study are available upon request. PLOS only allows data to be available upon request if there are legal or ethical restrictions on sharing data publicly. For more information on unacceptable data access restrictions, please see http://journals.plos.org/plosone/s/data-availability#loc-unacceptable-data-access-restrictions.

In your revised cover letter, please address the following prompts:

a) If there are ethical or legal restrictions on sharing a de-identified data set, please explain them in detail (e.g., data contain potentially sensitive information, data are owned by a third-party organization, etc.) and who has imposed them (e.g., an ethics committee). Please also provide contact information for a data access committee, ethics committee, or other institutional body to which data requests may be sent.

b) If there are no restrictions, please upload the minimal anonymized data set necessary to replicate your study findings as either Supporting Information files or to a stable, public repository and provide us with the relevant URLs, DOIs, or accession numbers. For a list of acceptable repositories, please see http://journals.plos.org/plosone/s/data-availability#loc-recommended-repositories.

We will update your Data Availability statement on your behalf to reflect the information you provide.

3. PLOS ONE now requires that authors provide the original uncropped and unadjusted images underlying all blot or gel results reported in a submission’s figures or Supporting Information files. This policy and the journal’s other requirements for blot/gel reporting and figure preparation are described in detail at https://journals.plos.org/plosone/s/figures#loc-blot-and-gel-reporting-requirements and https://journals.plos.org/plosone/s/figures#loc-preparing-figures-from-image-files. When you submit your revised manuscript, please ensure that your figures adhere fully to these guidelines and provide the original underlying images for all blot or gel data reported in your submission. See the following link for instructions on providing the original image data: https://journals.plos.org/plosone/s/figures#loc-original-images-for-blots-and-gels. In your cover letter, please note whether your blot/gel image data are in Supporting Information or posted at a public data repository, provide the repository URL if relevant, and provide specific details as to which raw blot/gel images, if any, are not available. Email us at plosone@plos.org if you have any questions.

4. Please review your reference list to ensure that it is complete and correct. If you have cited papers that have been retracted, please include the rationale for doing so in the manuscript text, or remove these references and replace them with relevant current references. Any changes to the reference list should be mentioned in the rebuttal letter that accompanies your revised manuscript. If you need to cite a retracted article, indicate the article’s retracted status in the References list and also include a citation and full reference for the retraction notice.

[Note: HTML markup is below. Please do not edit.]

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

1. Is the manuscript technically sound, and do the data support the conclusions?

The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented.

Reviewer #1: Yes

********** 

2. Has the statistical analysis been performed appropriately and rigorously?

Reviewer #1: Yes

********** 

3. Have the authors made all data underlying the findings in their manuscript fully available?

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.

Reviewer #1: Yes

********** 

4. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer #1: Yes

********** 

5. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer #1: In the manuscript by Hall et al., together with their previous paper (ref. 18-20) the authors generated Mgat1 (encodes GnT-I) knock out neuroblastoma cells by CRIPR/Cas9 and obtained mutant cells with aberrant N-glycosylation. The mutant cells showed altered cell morphology and growth properties compared to wild-type parental cells. The authors also showed that the expression of several proteins including MMP, receptor-tyrosine kinase and cytoskeletal proteins were significantly changed in mutant cells.

The experiment seems to be well designed and conducted, and the results ae convincing to support their conclusion. The manuscript is well constructed and written in precise English.

Even though the manuscript largely lacks the mechanistic insights how N-glycans regulate and what proteins is most responsible for these cellular phenotypes, the phenomena itself might be informative to the reader of glycobiology and tumor biology.

I think the publication of the manuscript can be considered if the following concerns are addressed.

Major point

1. through the manuscript

GnT-1 and GnT-2 should be GnT-I and GnT-II (Roman, not Arabian)

2. The schematic drawing to show N-glycans structures and how GnT-I and GnT-II work on the structures should be briefly presented on Figure 1A for beginner readers.

3. Figure 1D

The samples should be run on the same gel and blotted on the same membrane for each blot.

4. Figure 9A

The image is very poor and the samples should be run on the same gel and blotted on the same membrane for each blot.

5. The authors should more discuss the relevance of their finding to the human clinical situations. For instances, human neuroblastoma is classified into stage 1 to 4 and 4S. Do you have any information about the expression of GnT-I with different stages?

Minor point

Lime 108

paladin>paladin

Line 132

two dimensional (2D) versus three dimensional (3D) > 2D and 3D

the abbreviations were already defined and not needed here

Figure 1C

“NB_1 (Mgat1)” should be “NB_1 (-Mgat1)”

Figure 2A

the scale bar should be included into the image

Figure 2B

What is OG? Outgrowth? “Neurite Length” and “Neurite Width” are better.

Figure 2D

Need the scale bar.

Figure 3B

Need the scale bar.

Figure 3C Y-axis

What is the unit?

Figure 3D

Need the scale bar.

Figure 5A and 5B

Need the scale bar

Figure 5C, Y-axis

Should be “Cell invasion index (ratio to spheroid size)”

Figure 5D, Y-axis

Need the unit pixels?

Figure 6

See the comment on Figure 5.

Figure 7B and 7D, Y-axis

Should be “Gelatinase activity (Mutant/NB_1)

Figure 8A

The cell line names are missing.

Figure 9C and 9D, Y-axis

Should be “Band intensity (Mutant/NB_1)” or “Relative expression (Mutant/NB_1)”.

********** 

6. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #1: Yes: Kazuma Sakamoto

[NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.]

While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step.

PLoS One. 2021 Nov 8;16(11):e0259743. doi: 10.1371/journal.pone.0259743.r002

Author response to Decision Letter 0


14 Oct 2021

Point-by-point comments to reviewer

5. Review Comments to the Author

We wish to thank the reviewer for a thorough review as the comments have improved the manuscript.

Authors’ answers to the questions above.

The answers to questions made by reviewer were positive. However, we have addressed availability of group data supporting the mean. Groups data has been uploaded as supplementary group data excel file. Also, we have attached a file: S1_Raw_images which has unmodified images of western blot, lectin blots, gelatinase gels and coomassie blue stained SDS gels.

Reviewer #1: In the manuscript by Hall et al., together with their previous paper (ref. 18-20) the authors generated Mgat1 (encodes GnT-I) knock out neuroblastoma cells by CRIPR/Cas9 and obtained mutant cells with aberrant N-glycosylation. The mutant cells showed altered cell morphology and growth properties compared to wild-type parental cells. The authors also showed that the expression of several proteins including MMP, receptor-tyrosine kinase and cytoskeletal proteins were significantly changed in mutant cells.

The experiment seems to be well designed and conducted, and the results ae convincing to support their conclusion. The manuscript is well constructed and written in precise English.

Even though the manuscript largely lacks the mechanistic insights how N-glycans regulate and what proteins is most responsible for these cellular phenotypes, the phenomena itself might be informative to the reader of glycobiology and tumor biology.

I think the publication of the manuscript can be considered if the following concerns are addressed.

Major point

1. through the manuscript

GnT-1 and GnT-2 should be GnT-I and GnT-II (Roman, not Arabian)

Authors response: This has been changed throughout the manuscript.

2. The schematic drawing to show N-glycans structures and how GnT-I and GnT-II work on the structures should be briefly presented on Figure 1A for beginner readers.

Authors response: A schematic drawing has been added as Figure 1A. The figure legend was updated, lines 300-303. The figure is stated in the text of the results, lines 292-294.

3. Figure 1D

The samples should be run on the same gel and blotted on the same membrane for each blot.

Figure 1D was changed to Figure 1E due to insertion of the schematic drawing requested by reviewer. The samples were run on the same blot as shown and can also be viewed in the S1_Raw_images file. We have removed lines on blots for clarification.

4. Figure 9A

The image is very poor and the samples should be run on the same gel and blotted on the same membrane for each blot.

The samples were run on the same blot as shown and can also be viewed in the S1_Raw_images file. For clarification purposes, we have removed lines on blots. In some cases, the 2D and 3D samples were separated by standards as shown in figure. The standard was included on blot to illustrate the samples were on the same blot.

5. The authors should more discuss the relevance of their finding to the human clinical situations. For instances, human neuroblastoma is classified into stage 1 to 4 and 4S. Do you have any information about the expression of GnT-I with different stages?

Currently, information is lacking about the expression of GnT- I with the various stages of NB. However, we have elaborated on GnT-I in favorable and unfavorable NB in the 2nd paragraph of the discussion.

“… Again, reinforcing the relative great cell invasiveness of NB_1(-Mgat1) cells. Based on our 3D cell invasion studies, NB cells expressing complex N-glycans were less invasive than those expressing exclusively oligomannose. As such, our current results support a past clinical NB study which showed that GnT-V, the enzyme which initiates β1,6-branchpoints, was of higher abundance in favorable stages (1, 2 and 4s) than unfavorable stages (3 and 4) of NB [26]. Thus, it would be of great interest to evaluate whether unfavorable NB patients have lowered expression of GnT-I in tumor tissues compared to those with favorable NB. Further the cell culturing technique appears to have a major impact on interpreting cell invasiveness of NB cells.”

Minor point

Lime 108

paladin>paladin

This has been corrected.

Line 132

two dimensional (2D) versus three dimensional (3D) > 2D and 3D

the abbreviations were already defined and not needed here

This has been corrected.

Figure 1C

“NB_1 (Mgat1)” should be “NB_1 (-Mgat1)”

This has been corrected.

Figure 2A

the scale bar should be included into the image

A scale bar (in µm) has been added.

Figure 2B

What is OG? Outgrowth? “Neurite Length” and “Neurite Width” are better.

Outgrowth has been changed to neurite. Also pixels have been converted to µm.

Figure 2D

Need the scale bar.

A scale bar (in µm) has been added.

Figure 3B

Need the scale bar.

A scale bar (in µm) has been added.

Figure 3C Y-axis

What is the unit?

µm2

Figure 3D

Need the scale bar.

A scale bar (in µm) has been added.

Figure 5A and 5B

Need the scale bar

A scale bar (in µm) has been added.

Figure 5C, Y-axis

Should be “Cell invasion index (ratio to spheroid size)”

Authors reply: The y-axis represents invasion area/sphere area.

Since there appeared to be some confusion, we changed the figure panels. Figure 5B shows how the invasion was calculated (invasion=invasive area – sphere area). The y-axis of figure 5C was changed to invasion area/sphere area. A reference for the analysis has been added in the methods (Berens EB, Holy JM, Riegel AT, Wellstein A. A Cancer Cell Spheroid Assay to Assess Invasion in a 3D Setting. Journal of visualized experiments : JoVE. 2015;(105). Epub 2015/12/10. doi: 10.3791/53409. PubMed PMID: 26649463; PubMed Central PMCID: PMCPMC4692745) (see line 244). Panel D represent plots of sphere area versus invasion area for each cell line to determine Pearson’s correlation coefficients between these two variables. The linear fits show a positive and significant correlation of the two variables, and the rationale for representing cell invasiveness of the different cell lines using the invasion/sphere versus cell line plot. The figure legend and results section has been changed accordingly.

Figure 5D, Y-axis

Need the unit pixels?

This panel has been removed and sphere area versus invasion area plot has been added. The units are in µm.

Figure 6

See the comment on Figure 5.

Scale bar has been added. The y-axis of Panels D,E,F have been changed as described above for figure 5. Panels with bar graphs of sphere area versus cell line have been removed.

Figure 7B and 7D, Y-axis

Should be “Gelatinase activity (Mutant/NB_1)

The label of Y-axis has been changed.

Figure 8A

The cell line names are missing.

The names of cell lines have been added.

Figure 9C and 9D, Y-axis

Should be “Band intensity (Mutant/NB_1)” or “Relative expression (Mutant/NB_1)”.

The y-axis was changed to Band intensity (Mutant/NB_1).

Attachment

Submitted filename: Point by point response to reveiwers.pdf

Decision Letter 1

Salvatore V Pizzo

26 Oct 2021

Functional analysis of N-acetylglucosaminyltransferase-I knockdown in 2D and 3D neuroblastoma cell cultures

PONE-D-21-18235R1

Dear Dr. Schwalbe,

We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements.

Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication.

An invoice for payment will follow shortly after the formal acceptance. To ensure an efficient process, please log into Editorial Manager at http://www.editorialmanager.com/pone/, click the 'Update My Information' link at the top of the page, and double check that your user information is up-to-date. If you have any billing related questions, please contact our Author Billing department directly at authorbilling@plos.org.

If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org.

Kind regards,

Salvatore V Pizzo

Academic Editor

PLOS ONE

Additional Editor Comments (optional):

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

1. If the authors have adequately addressed your comments raised in a previous round of review and you feel that this manuscript is now acceptable for publication, you may indicate that here to bypass the “Comments to the Author” section, enter your conflict of interest statement in the “Confidential to Editor” section, and submit your "Accept" recommendation.

Reviewer #1: All comments have been addressed

**********

2. Is the manuscript technically sound, and do the data support the conclusions?

The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented.

Reviewer #1: Yes

**********

3. Has the statistical analysis been performed appropriately and rigorously?

Reviewer #1: Yes

**********

4. Have the authors made all data underlying the findings in their manuscript fully available?

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.

Reviewer #1: Yes

**********

5. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer #1: Yes

**********

6. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer #1: The authors well addressed my concerns.

I do not have additional requirements and recommend the publication of the manuscript in PLOS One.

**********

7. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #1: Yes: Kazuma Sakamoto

Acceptance letter

Salvatore V Pizzo

28 Oct 2021

PONE-D-21-18235R1

Functional analysis of N-acetylglucosaminyltransferase-I knockdown in 2D and 3D neuroblastoma cell cultures

Dear Dr. Schwalbe:

I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now with our production department.

If your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information please contact onepress@plos.org.

If we can help with anything else, please email us at plosone@plos.org.

Thank you for submitting your work to PLOS ONE and supporting open access.

Kind regards,

PLOS ONE Editorial Office Staff

on behalf of

Dr. Salvatore V Pizzo

Academic Editor

PLOS ONE

Associated Data

    This section collects any data citations, data availability statements, or supplementary materials included in this article.

    Supplementary Materials

    S1 Raw images

    (PDF)

    S1 Data. Group data of Figs 19.

    (XLSX)

    Attachment

    Submitted filename: Point by point response to reveiwers.pdf

    Data Availability Statement

    All relevant data are within the manuscript and its supporting information files.


    Articles from PLoS ONE are provided here courtesy of PLOS

    RESOURCES